
UCT Scientists to commence phase one clinical trial of COVID-19 candidate
Loading player...
UCT is expected to commence phase one clinical trial of COVID-19 vaccine candidate hAd5 T-cell. The trial comes after approval from the South African Health Products Regulatory Authority (SAHPRA). We now chat to second chair in the department of medicine at UCT, Professor Graeme Meintjes